Members of SMC and Oval Medical Technologies will be available in booth #29 during exhibition hours to discuss Oval’s 4 customizable drug-delivery combination platforms that are making a positive difference in patients’ lives.
Oval Medical Technologies’ Jonathan Bradshaw, Device Development Engineer, and Susie White, Mechanical Engineer, discuss designing an autoinjector capable of delivering highly viscous drug formulations with minimal impact on the patient in the latest issue of OnDrug Delivery Magazine. Download the white paper – Combining Human Needs With High Viscosity Formulations here.
SMC Ltd. and Oval Medical Technologies will be attending PDA’s Universe of Pre-filled Syringes and Injection Devices in Orlando, Florida – October 8-9. Jonathan Bradshaw and Susie White, Oval Medical – will be presenting two posters: High Viscosity Formulations: Developing a Human Solution to Autoinjector Design and High Viscosity Formulations: Developing an effective Primary Drug Container System. Members of both teams will be available to discuss scalable manufacturing of combination products and answer questions about design, manufacturing, drug handling, and automation. Stop by booth 416 and 418 to review Oval’s 4 customizable drug-delivery combination platforms that are making a positive difference in patients’ lives.
Over the past 15 years, numerous changes have taken place in the Med Tech industry. As part of MPO’s Editorial board, SMC Ltd’s Barbara Tichart was one of 15 industry participants contributing to MPO’s article 15-Year Anniversary: A reflection on Industry Changes Over MPO’s Lifetime. Click here to read the article.
SMC Ltd. will be attending MD&M West – February 6-8 in Anaheim, CA. From design to scalable production manufacturing of finished devices, SMC can partner with you on your next diagnostics, pharmaceutical or medical device. Stop by our booth #2913 to discuss your project.
Join SMC Ltd. and Oval Medical Technologies at the Pharmapack Paris show February 7-8. Members of SMC and Oval Medical Technologies will be available during exhibition hours to answer questions and show how we are changing the auto-injector market with patent centric design and total manufacturing. Stop by our location F34 to discuss your project.
On February 1, 2018 SMC Ltd. will celebrate our 30th Anniversary. “Thirty years ago, we set the goal to create a plastics molding company using scientific molding with ‘speed-to-market’ as foundations of our service. It was a bold idea and many people questioned why we would want to create one more plastics company. Today SMC is a global leader in Contract Manufacturing for the Medical Device, Diagnostics and Pharmaceutical industries. With 30 years behind us, we are well-positioned for the next 30 years and I look forward to this future. Thank you to all of our employees and our global customers. Chetan N. Patel –CEO and Founder
SMC Ltd. and Oval Medical will be attending PDA’s Universe of Pre-filled Syringes and Injection Devices in Vienna, Austria – November 7-8. Jonathan Lawson, Oval Medical – Senior Design Engineer, will be presenting: Polymeric PDC Technology: An Integrated Approach to Autoinjector Design. Members of both teams will be available to discuss scalable manufacturing of combination products and to answer questions about design, manufacturing, drug handling, and automation. Stop by booth 100 and 101 to discuss how we can partner on your next Drug Delivery Device.
Join SMC Ltd. and Oval Medical at the PODD Conference – Oct 19-20 in Boston, MA Pete Evans, Oval’s Director of Device Development, will present Using Polymeric PDC Technology to Improve Auto-Injector Design, during the Injectable Technologies Track 1B, October 19 at 4:30 p.m. Members of SMC and Oval Medical Technologies will be available during exhibition hours to answer questions and show how we are changing the auto-injector market with patent centric design into total manufacturing.
SMC Ltd. is among 15 winners of the Massachusetts Economic Impact awards for 2017. SMC Devens received the central region’s bronze award on the basis of job growth, facility expansion, investment and community involvement since January 1, 2016. To learn more, please read the press release here.